Patients With Diabetes Have Comparable Health Expenses After RYGB or Sleeve Gastrectomy
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 28, 2025 -- For patients with diabetes undergoing Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), overall expenditures decrease in the postsurgical period, with no differences seen following the first six months after surgery, according to a study published online Jan. 28 in the Annals of Internal Medicine.
Matthew L. Maciejewski, Ph.D., of Duke University in Durham, North Carolina, and colleagues compared health expenditures three years before and 5.5 years after bariatric surgery among patients with diabetes undergoing RYGB (3,147 patients) or SG (3,510 patients) from 2012 to 2019.
The researchers found that per six-month period, there was about a 30 percent decrease in expenditures for both groups, from $4,039.06 to $2,441.13 before and after RYGB and from $3,918.37 to $2,658.15 before and after SG. Through 5.5 years, there was no significant difference between the groups in total expenditures after surgery, except for the first six months, when expenditures were transiently higher in the RYGB group (difference, $564.32). This was driven by a higher rate of inpatient admission. Postsurgical outpatient and medication expenditures did not differ between the groups.
"These findings suggest that RYGB and SG do not substantially differ in reducing long-term health care costs for patients with type 2 diabetes," the authors write. "The substantial cost savings observed are primarily driven by reductions in medication expenditures, highlighting the economic benefits of bariatric surgery in managing diabetes."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes
FRIDAY, July 18, 2025 -- In a joint clinical practice guideline issued by the Endocrine Society and European Society of Endocrinology, recommendations are presented for pregnancy...
Long-Term Obesity Linked to Expression of Aging Biomarkers
THURSDAY, July 17, 2025 -- Long-term obesity is associated with the expression of biomarkers denoting antagonistic and integrative aging hallmarks in adults aged 28 to 31 years...
ENDO: Older Age, Female Sex Tied to Greater Muscle Loss With Semaglutide
THURSDAY, July 17, 2025 -- Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide, and greater muscle loss is...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.